Publications by authors named "Markus Raderer"

Claim this Profile
C
Comparisons of treatment performance and therapy sequences in neuroendocrine neoplasms using progression-free survival ratios.
Philipp Melhorn, Elisabeth Kretschmer-Chott, Peter Mazal, Markus Raderer, Barbara Kiesewetter

Eur J Nucl Med Mol Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
K11.1 (hERG1)-centered macromolecular membrane complexes regulate proliferation in B cell lymphomas and constitute novel pharmacological targets.
Cesare Sala, Jessica Iorio, Claudia Duranti, Alberto Montalbano, Laura Clara Grandi, Markus Raderer

Pharmacol Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete remission of bronchus-associated lymphoid tissue lymphoma after antibiotic treatment for Tropheryma whipplei.
Teresa Antonia Kiener, Gregor Schweighofer-Zwink, Gundula Rendl, Jan Marco Kern, Lenka Baskova, Markus Raderer

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Biomarkers in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy.
Christopher Mann, Ulrike Pailer, Andreas Spannbauer, Fardin Hamidi, Aliza Veronika Braser, Markus Raderer

JACC Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Availability and characteristics of clinical trials for neuroendocrine tumors: Is there an unmet need?
Philipp Melhorn, Amirhossein Sadeghi, Markus Raderer, Barbara Kiesewetter

Eur J Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term experience with octreotide and lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumors.
Barbara Kiesewetter, Friedrich Franz Pflüger, Philipp Melhorn, Peter Mazal, Markus Raderer

Clin Transl Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylation Profiles Differ According to Clinical Characteristics in Well-Differentiated Neuroendocrine Tumors of the Lung.
Philipp Melhorn, Erwin Tomasich, Alissa Blessing, Luka Brcic, Angelika Kogler, Markus Raderer

Endocr Pathol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous Transcatheter Pulmonary and Tricuspid Valve Replacement in Carcinoid Heart Disease.
Varius Dannenberg, Caglayan Demirel, Markus Raderer, Barbara Kiesewetter, Lukas Reider

JACC Case Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The myth of a cancer-specific temperament: An analysis of affective temperament in cancer patients.
Elisabeth L Zeilinger, Matthias Knefel, Andreas Erfurth, Denise Andrzejewski, Otto Lesch, Markus Raderer

J Psychosom Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selecting systemic treatment for metastatic neuroendocrine tumors of the lung-current evidence and clinical implications.
Philipp Melhorn, Markus Raderer, Barbara Kiesewetter

Cancer Treat Rev· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and outcomes of current antitumor therapy for high-grade neuroendocrine neoplasms: perspective of a tertiary referral center.
Philipp Melhorn, Julia Spitzer, Thomas Adel, Ladislaia Wolff, Peter Mazal, Markus Raderer

J Cancer Res Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological Characteristics of Extranodal Marginal Zone Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT-Lymphoma) of the Intestine: A Single Center Analysis.
Oskar Steinbrecher, Barbara Kiesewetter, Werner Dolak, Rosa Brand, Ingrid Simonitsch-Klupp, Markus Raderer

Hematol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver metastases in high-grade neuroendocrine neoplasms: A comparative study of hepatic tumor volume and biochemical findings in NET G3 versus NEC.
Philipp Melhorn, Markus Raderer, Peter Mazal, Luzia Berchtold, Lucian Beer

J Neuroendocrinol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Current developments in the treatment of neuroendocrine tumors].
Barbara Kiesewetter-Wiederkehr, Philipp Melhorn, Christian Scheuba, Markus Raderer

Radiologie (Heidelb)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and biopsychosocial indicators of fatigue in cancer patients.
Elisabeth L Zeilinger, Irina Zrnic-Novakovic, Claudia Oppenauer, Matthäus Fellinger, Matthias Knefel, Markus Raderer

Cancer Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study.
Marianne Pavel, Harald Lahner, Dieter Hörsch, Anja Rinke, Timm Denecke, Markus Raderer

Oncologist· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
Rudolf Werner, Alexander Haug, Christian Buske, Simon Heidegger, Anna L Illert, Markus Raderer

Nuklearmedizin· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative schedule of temozolomide/capecitabine in neuroendocrine neoplasms.
Philipp Melhorn, Peter Mazal, Ladislaia Wolff, Petar Popov, Elisabeth Kretschmer-Chott, Markus Raderer

Endocr Relat Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From biology to clinical practice: antiproliferative effects of somatostatin analogs in neuroendocrine neoplasms.
Philipp Melhorn, Peter Mazal, Ladislaia Wolff, Elisabeth Kretschmer-Chott, Markus Raderer

Ther Adv Med Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [F]FDG.
Aleksander Kosmala, Johannes Duell, Simone Schneid, Sebastian E Serfling, Takahiro Higuchi, Markus Raderer

Eur J Nucl Med Mol Imaging· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases - data from a tertiary care center.
Petar Popov, Ariane Steindl, Ladislaia Wolff, Elisabeth S Bergen, Franziska Eckert, Markus Raderer

Clin Exp Metastasis· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning for [F]fluorodeoxyglucose-PET-CT classification in patients with lymphoma: a dual-centre retrospective analysis.
Ida Häggström, Doris Leithner, Jennifer Alvén, Gabriele Campanella, Murad Abusamra, Markus Raderer

Lancet Digit Health· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma.
Johannes Duell, Andreas K Buck, Philipp E Hartrampf, Wiebke Schlötelburg, Simone Schneid, Markus Raderer

J Nucl Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Affective temperament, fatigue, and pain in cancer patients.
Matthias Knefel, Elisabeth L Zeilinger, Andreas Erfurth, Simone Lubowitzki, Otto Lesch, Markus Raderer

J Affect Disord· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of COVID-19 and socioeconomic status on psychological distress in cancer patients.
Elisabeth Lucia Zeilinger, Matthias Knefel, Carmen Schneckenreiter, Jakob Pietschnig, Simone Lubowitzki, Markus Raderer

Int J Clin Health Psychol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis